Stay updated on Orally Administered AG-120 in Hematologic Malignancies Clinical Trial
Sign up to get notified when there's something new on the Orally Administered AG-120 in Hematologic Malignancies Clinical Trial page.

Latest updates to the Orally Administered AG-120 in Hematologic Malignancies Clinical Trial page
- Check5 days agoChange DetectedA new site revision entry v3.6.2 was added to the history, and the previous entry v3.6.0 was removed. This represents a minor background release update to the site rather than changes to the study data or public study information.SummaryDifference0.1%

- Check12 days agoChange DetectedA new 'Study Status' entry was added to the record history with associated date markers (2026-06-15 and 2026-06-11) and the value 50, while the existing entry from 2025-06-08 was deleted, updating the history timeline to reflect the latest status information.SummaryDifference0.2%

- Check19 days agoChange DetectedNew quick-access links for joining eligibility and contact information were added to the study record history page, and the site revision was updated from v3.5.5 to v3.6.0.SummaryDifference0.3%

- Check26 days agoChange DetectedThe page footer revision tag was updated from v3.5.4 to v3.5.5, signaling a new build of the page. This change does not alter study data or visible content beyond the version tag.SummaryDifference0.1%

- Check48 days agoChange DetectedA new revision entry 'Revision: v3.5.4' was added to the record history and the previous 'Revision: v3.5.3' entry was removed, indicating an update to the site's version reflected in the history log.SummaryDifference0.1%

- Check69 days agoChange DetectedThis change updates the ClinicalTrials.gov page’s displayed revision/build label from v3.5.2 to v3.5.3, indicating a platform/version release rather than a study-record update.SummaryDifference0.1%

Stay in the know with updates to Orally Administered AG-120 in Hematologic Malignancies Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Orally Administered AG-120 in Hematologic Malignancies Clinical Trial page.